#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Oesophageal adenocarcinoma stage III Rhabdomyosarcoma PIK3CA related overgrowth spectrum Oesophageal adenocarcinoma Spinal cord injury Piriformis syndrome Hepato-lenticular degeneration Endometrial cancer Adrenogenital syndrome MELAS syndrome Vaginal cancer Obesity Hypocalcaemia Cutaneous T-cell lymphoma Autoinflammation with infantile enterocolitis More trials…

    Learn about Rare Diseases

    Gastrointestinal stromal tumour Rhabdoid tumour IgA nephropathy – Treatment Factor VIII deficiency – Life with Disease Basal cell naevus syndrome – Diagnostics Pituitary-dependent Cushing’s syndrome Cytokine release syndrome – Basic Information CADASIL KBG syndrome – Trials in Disease Hereditary ataxia – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    GSKVX000000070965 Hydroxi-Methionine Calcium Mdna11 Luspatercept Atropine Sulfate Febuxostat Hemihydrate Clarithromycin Tadekinig Alfa LYSERGIDE Rhh646 Diclofenac Sodium Int-787 STREPTOCOCCUS VIRIDANS Edoxaban Amniotic Membrane, Human Bio89-100 Indocyanine Green Ibuprofen Sodium Dihydrate ATIRMOCICLIB Troriluzole More therapies…

    Learn about Your Condition

    Biliary tract disorder Migraine without aura Choroidal dystrophy Epilepsy Schizoaffective disorder Neurodevelopmental disorder Haemorrhagic stroke Sickle cell anaemia Adenovirus infection Lung adenocarcinoma Myocarditis post infection Pterygium Ataxia telangiectasia Burning mouth syndrome Dermatomyositis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Liver Fibrosis Assessment Using 68Ga-FAPI-46 Imaging in Patients with Suspected or Confirmed Nonalcoholic Steatohepatitis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Metabolic dysfunction-associated steatohepatitis
    Investigated Drugs:
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    France

  • Study of sonelokimab and risankizumab in adults with psoriatic arthritis who did not respond well to previous TNF inhibitor treatment

    Recruiting

    3 1 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Sonelokimab
    • Risankizumab
    Bulgaria Czechia France Germany Hungary Poland +1

  • Study on the Safety of T-Guard (Dafsolimab Setaritox, Grisnilimab Setaritox) for Patients with Early Diffuse Cutaneous Systemic Sclerosis

    Recruiting

    1 1 1
    Investigated Diseases:
    • Systemic scleroderma
    Investigated Drugs:
    • GRISNILIMAB SETARITOX
    The Netherlands

  • Study on Zoledronic Acid and Placebo Before Parathyroid Surgery in Patients with Primary Hyperparathyroidism

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hyperparathyroidism primary
    Investigated Drugs:
    • Zoledronic Acid
    • Sodium Chloride
    Denmark

  • Study on Sodium Fluoride (18F) PET-CT Scans for Detecting Bone Changes in Psoriasis Patients at Risk of Psoriatic Arthritis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Sodium Fluoride (18F)
    The Netherlands

  • Study on Treating Neovascular Age-Related Macular Degeneration with Aflibercept, Ranibizumab, and Brolucizumab for Patients with Active Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Age-related macular degeneration
    Investigated Drugs:
    • BROLUCIZUMAB
    • Ranibizumab
    • Aflibercept
    Austria
Previous Page
1 … 247 248 249 250 251 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!